Developing vaccines to combat antibiotic-resistant infections and bioterrorism threats
Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases
['FUNDING_OTHER'] · INTRAVACC B.V. · NIH-11091390
This study is working on new vaccines to help protect against infections from tough bacteria that don't respond to regular antibiotics, and it's aimed at making sure these vaccines are safe and effective for people when they need them most.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INTRAVACC B.V. (nih funded) |
| Locations | 1 site (BILTHOVEN, NETHERLANDS) |
| Trial ID | NIH-11091390 on ClinicalTrials.gov |
What this research studies
This research focuses on creating advanced vaccine candidates aimed at preventing and treating infectious diseases, particularly those caused by antibiotic-resistant bacteria. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness and safety through nonclinical studies in animal models. The ultimate goal is to prepare these vaccines for clinical trials, ensuring they are safe and effective for human use in response to outbreaks or bioterrorism events.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of contracting antibiotic-resistant infections or those living in areas prone to infectious disease outbreaks.
Not a fit: Patients who are not at risk for antibiotic-resistant infections or those with existing conditions that preclude vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
BILTHOVEN, NETHERLANDS
- INTRAVACC B.V. — BILTHOVEN, NETHERLANDS (ACTIVE)
Researchers
- Principal investigator: OOSTERHOFF, DINJA — INTRAVACC B.V.
- Study coordinator: OOSTERHOFF, DINJA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Disease Outbreaks, Emerging Communicable Diseases